LEAP-014: an Open-Label, Randomized, Phase 3 Study of First-Line Lenvatinib Plus Pembrolizumab Plus Chemotherapy in Esophageal Squamous Cell Carcinoma
ANNALS OF ONCOLOGY（2022）
关键词
Combination Therapies
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要